Applied Genetic Technologies (AGTC) Reports Q2 Loss of $0.29/Share

Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of ($0.29), versus $0.10 reported last year. Revenue for the quarter came in at $4.85 million, versus $10.9 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c